Voices
Cristhiam Mauricio Rojas Hernandez: Advancing Care for Immune Checkpoint Therapy Complications at MD Anderson
Yinghong Wang and Cristhiam Mauricio Rojas Hernandez

Cristhiam Mauricio Rojas Hernandez: Advancing Care for Immune Checkpoint Therapy Complications at MD Anderson

Cristhiam Mauricio Rojas Hernandez, Associate Professor of Hematology at MD Anderson Cancer Center, shared a post on LinkedIn:

“Happy to share MD Anderson Cancer Center and its efforts to make its expertise available to help for the care of immune checkpoint inhibitor therapy complications. Special recognition to Yinghong (Mimi) Wang for her leadership in our Immunotoxicity group, and to all of our national and international collaborators.

Read further.”

Other articles featuring MD Anderson Cancer Center on OncoDaily.

cancer Cristhiam Mauricio Rojas Hernandez MD Anderson Cancer Center OncoDaily Oncology